DK0410749T3 - Anthocyanidiner til behandling af ophthalmiske sygdomme - Google Patents

Anthocyanidiner til behandling af ophthalmiske sygdomme

Info

Publication number
DK0410749T3
DK0410749T3 DK90308197.4T DK90308197T DK0410749T3 DK 0410749 T3 DK0410749 T3 DK 0410749T3 DK 90308197 T DK90308197 T DK 90308197T DK 0410749 T3 DK0410749 T3 DK 0410749T3
Authority
DK
Denmark
Prior art keywords
anthocyanidins
delphidin
pelargonidin
treatment
subject
Prior art date
Application number
DK90308197.4T
Other languages
Danish (da)
English (en)
Inventor
Maria Jose Magistretti
Giorgio Pifferi
Marisa Conti
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Application granted granted Critical
Publication of DK0410749T3 publication Critical patent/DK0410749T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Medicinal Preparation (AREA)
DK90308197.4T 1989-07-28 1990-07-26 Anthocyanidiner til behandling af ophthalmiske sygdomme DK0410749T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898917323A GB8917323D0 (en) 1989-07-28 1989-07-28 Methods and pharmaceutical compositions for the treatment of ophthalmic diseases

Publications (1)

Publication Number Publication Date
DK0410749T3 true DK0410749T3 (da) 1994-11-14

Family

ID=10660801

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90308197.4T DK0410749T3 (da) 1989-07-28 1990-07-26 Anthocyanidiner til behandling af ophthalmiske sygdomme

Country Status (11)

Country Link
US (1) US5196449A (de)
EP (1) EP0410749B1 (de)
JP (1) JP2967523B2 (de)
KR (1) KR0149026B1 (de)
AT (1) ATE112960T1 (de)
DE (1) DE69013431T2 (de)
DK (1) DK0410749T3 (de)
GB (1) GB8917323D0 (de)
HK (1) HK124595A (de)
IT (1) IT1245717B (de)
PT (1) PT94848A (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2673513B1 (fr) * 1991-03-05 1993-10-29 Institut Recherche Biologique Sa Nouvelles compositions dietetiques a base de lipides phosphoryles et leur utilisation dans l'amelioration des troubles de la vision.
JP3414446B2 (ja) * 1993-07-23 2003-06-09 財団法人相模中央化学研究所 ヒドロキシシリル基を末端に有するポリオキシエチレン化合物、四級塩を末端に有するブロック共重合体、および経皮吸収促進剤
JPH1059846A (ja) * 1996-06-10 1998-03-03 Kikkoman Corp 白内障の予防または治療薬剤
ES2303509T3 (es) * 1999-07-02 2008-08-16 Meiji Seika Kaisha, Ltd. Composiciones para alimentos, proceso para su produccion y alimentos y bebidas funcionales que las contienen.
FR2811550B1 (fr) * 2000-07-11 2003-02-14 Oreal Composition a base de vitamines et de sels mineraux, pour diminuer la chute des cheveux et/ou favoriser la repousse des cheveux
US7014991B2 (en) * 2001-11-16 2006-03-21 Infinite Vision, Llc Use of injectable dyes for staining an anterior lens capsule and vitreo-retinal interface
EP1681297A4 (de) 2003-10-30 2009-06-17 Meiji Seika Kaisha Inhibitor der tyrosinaseaktivität und mittel zum verbessern der durchblutung des gesichts
JP4873904B2 (ja) * 2005-08-22 2012-02-08 国立大学法人弘前大学 眼血管血流障害改善剤
FR2975008B1 (fr) * 2011-05-13 2014-03-07 Inst Biophytis Utilisation de composes et composition pour le traitement de la degenerescence maculaire liee a l'age (dmla)
JP2013163669A (ja) * 2012-01-12 2013-08-22 Oriza Yuka Kk 可視光誘発網膜障害抑制剤及びそれを用いた眼疾患予防・治療剤

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1589294A (en) * 1976-09-08 1981-05-13 Inverni Della Beffa Spa Pharmaceutical compositions containing anthocyanidines
FR2378272A1 (fr) * 1977-01-25 1978-08-18 Ferodo Sa Dispositif dynamometrique de mesure de couple pour engin a fleche de levage a commande par verin
BE864450R (fr) * 1978-03-01 1978-07-03 Inverni Della Beffa Spa Compositions pharmaceutiques a base d'anthocyanidine, leur preparation et leur utilisation
FR2461499A1 (fr) 1979-07-23 1981-02-06 Inverni Della Beffa Spa Composition pharmaceutique a base d'extraits de myrtille
GB8518289D0 (en) * 1985-07-19 1985-08-29 Inverni Della Beffa Spa Obtaining proanthocyanidine a2
DE3670570D1 (de) * 1986-09-02 1990-05-31 Alcon Lab Inc Aldose-reductase-hemmer, nuetzlich bei der behandlung von glaukom.

Also Published As

Publication number Publication date
DE69013431D1 (de) 1994-11-24
KR0149026B1 (ko) 1998-10-15
IT1245717B (it) 1994-10-14
GB8917323D0 (en) 1989-09-13
US5196449A (en) 1993-03-23
IT9020968A0 (it) 1990-07-18
EP0410749A3 (en) 1993-02-03
HK124595A (en) 1995-08-11
JPH0381220A (ja) 1991-04-05
EP0410749A2 (de) 1991-01-30
ATE112960T1 (de) 1994-11-15
KR910002442A (ko) 1991-02-25
EP0410749B1 (de) 1994-10-19
IT9020968A1 (it) 1992-01-18
PT94848A (pt) 1991-04-18
JP2967523B2 (ja) 1999-10-25
DE69013431T2 (de) 1995-02-23

Similar Documents

Publication Publication Date Title
DE68929563D1 (de) Prostaglandin-Derivate zur Behandlung von Glaukom und ocularer Hypertension
ATE241365T1 (de) Saccharid-enthaltende zubereitungen zur behandlung von alzheimerschen erkrankung und von weiteren amyloidosen
NO912410L (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocyklen-derivater.
SE8102193L (sv) Terapeutiskt aktiv organisk forening och dess anvendning
ATE179888T1 (de) Ophthalmische zubereitung zur behandlung oder prävention von trockenem auge und krankheiten, die dadurch verursacht werden, enthaltend 12- sulfodehydroabietsäure
DE69327432D1 (de) Heilmittel für wunden und hämorrhoiden
UA35567C2 (uk) Фармацевтичний препарат для лікування хворих з порушеннями функції коагуляції, спосіб лікування таких хворих, спосіб одержання фармацевтичного препарату
RU93032613A (ru) Фармацевтический препарат для лечения пациентов с пролонгированным временем коагуляции, способ лечения пациентов, применение epi ингибитора для получения фармацевтического препарата
DE69521536D1 (de) Zusammensetzungen die G-CSF und ein TNF-Bindungsprotein enthalten
DE69930271T8 (de) Medizinische zusammensetzungen zur behandlung von augenerkrankungen
DK0410749T3 (da) Anthocyanidiner til behandling af ophthalmiske sygdomme
KR890001580A (ko) B형 간염 바이러스에 의해 유발되는 염증 질환을 치료하는 이중가닥 rna를 함유하는 약물
ATE161725T1 (de) Verwendung von phosphatdiestern zur behandlung von erkrankungen der retina
BG100599A (en) Antiviral form and therapeutical method
DE69007065D1 (de) Verwendung von Diadenosin-5',5'''-p1,p4-tetraphosphat zur Herstellung eines Arzneimittels zur Behandlung von Herzkrankheiten.
DE68901172D1 (de) (-)-2-pyrazolinverbindung, deren optischen aufspaltung und therapeutisches agens zur behandlung von zerebralen gefaesskrankheiten, diese verbindung als aktives ingredient enthaltend.
HU911272D0 (en) Process for the production of medical preparations containing hexetidine
ATE128358T1 (de) Therapeutische mittel für diabetisches gangrän.
DE3585312D1 (de) Anwendung von 1,6-dimethyl-4-oxo-1,6,7,8,9a-hexahydro-4h-pyrido(1,2-a)pyrimidin-3-carboxamid zur vorbeugung und behandlung von gastrointestinalschaeden.
KR890001555A (ko) 요산 배설용 조성물
BG96092A (bg) Тиенотиопиранови сулфонамидни производни и приложението им в офталмологични препарати
RU99103787A (ru) Способ лечения у детей болезни шойермана-мау
RU93048568A (ru) 14,14,14-трифтор-12-оксатетрадекановая кислота, липидный ингибитор вируса иммунодефицита человека